封面
市場調查報告書
商品編碼
1373760

全球腦植入市場 - 市場規模、佔有率和成長分析:按類型、應用和最終用戶 - 行業預測(2023-2030)

Global Brain Implant Market Size, Share, Growth Analysis, By Type(Deep brain stimulation (DBS) and vagus nerve stimulation (VNS).), By Application(Parkinson's disease, epilepsy), By End user(Hospitals, neurology clinics) - Industry Forecast 2023-2030

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2021年全球腦植入市場規模為12.5億美元,2022年為14億美元。預計該市場在預測期(2023-2030年)將以12.2%的年複合成長率成長,到2030年將達到35.2億美元。

在技​​術進步和神經系統疾病盛行率上升的推動下,全球腦植入市場正在穩步成長。腦植入物,也稱為神經植入物或神經假體,是一種與大腦連接以診斷、監測和治療各種神經系統疾病的植入式醫療設備。腦植入物的應用範圍從癲癇管理和帕金森氏症治療到認知增強和腦機介面,提供了一種有前途的治療選擇。市場上的主要參與企業,包括美敦力(Medtronic)、雅培實驗室(Abbott Laboratories)和波士頓科學公司(Boston Scientific),正在投資研發以推進腦植入技術。小型化、改進的電極設計以及與人工智慧演算法的整合技術進步正在提高大腦植入物的有效性和安全性。然而,隨著該領域的不斷發展,需要解決圍繞大腦植入的倫理和隱私考慮,例如知情同意和資料保護。

帕金森氏症、癲癇和慢性疼痛等神經系統疾病的罹患率和盛行率不斷上升,推動了對腦植入技術的需求。這些植入物為控制症狀和改善患者的生活品質提供了有效的治療選擇。

全球腦植入市場的主要市場趨勢之一是日益關注植入裝置的小型化和無線連接。技術的進步導致了更小、更緊湊的大腦植入物的開發,使外科手術的侵入性更小,並提高了患者的舒適度。微型植入物提供了微創或非侵入性方法的可能性,例如經顱磁刺激(TMS)和非侵入性電刺激。這些進步對於可能受益於長期植入的患者尤其重要,因為小型化裝置降低了併發症的風險並且更容易植入和移除。

該報告研究了全球腦植入市場,並提供了市場概述,包括按類型、應用、最終用戶、地區和參與市場的公司概況分類的趨勢。

目錄

執行摘要

母市場分析

市場規模

  • 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務

關鍵市場洞察

  • 技術分析
  • 價格分析
  • 供應鏈分析
  • 價值鏈分析
  • 市場生態系統
  • 智慧財產權分析
  • 趨勢分析
  • 啟動分析
  • 原料分析
  • 創新矩陣
  • 研發線產品分析
  • 總體經濟指標
  • 頂級投資分析
  • 關鍵成功因素
  • 競爭程度

市場動態及展望

  • 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
  • 法規狀況
  • 波特分析

全球腦植入市場,依類型

  • 市場概況
  • 深部腦部刺激 (DBS) 和迷走神經刺激 (VNS)

全球腦植入物市場(按應用)

  • 市場概況
  • 帕金森氏症
  • 癲癇
  • 其他

全球腦植入市場,依最終用戶分類

  • 市場概況
  • 醫院
  • 神經內科門診
  • 其他

全球腦植入市場,按地區

  • 市場概況
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

競爭形勢

  • 主要企業簡介
    • Medtronic
    • Abbott Laboratories
    • Boston Scientific Corporation
    • NeuroPace
    • Cochlear Limited
    • LivaNova PLC
    • Stryker Corporation
    • Nevro Corporation
    • NDI Medical
    • Nihon Kohden Corporation
    • Second Sight Medical Products, Inc.
    • Aleva Neurotherapeutics SA
    • Renishaw plc
    • Cyber??onics, Inc.
    • Neuronetics, Inc.
    • Natus Medical Incorporated
    • BrainLab AG
    • St. Jude Medical, Inc.
    • NeuroSigma, Inc.
    • Alpha Omega Engineering
簡介目錄
Product Code: SQMIG45A2096

Global Brain Implant Market size was valued at USD 1.25 billion in 2021 and is poised to grow from USD 1.4 billion in 2022 to USD 3.52 billion by 2030, at a CAGR of 12.2% during the forecast period (2023-2030).

The global brain implant market has been experiencing steady growth, driven by advancements in technology and a rising prevalence of neurological disorders. Brain implants, also known as neural implants or neuroprosthetics, are implanted medical devices that interface with the brain to diagnose, monitor, and treat various neurological conditions. With applications ranging from epilepsy management and Parkinson's disease treatment to cognitive enhancement and brain-computer interfaces, brain implants offer promising therapeutic options. Key players in the market, including Medtronic, Abbott Laboratories, and Boston Scientific, invest in research and development to advance brain implant technologies. Technological advancements, such as miniaturization, improved electrode designs, and integration with artificial intelligence algorithms, are enhancing the efficacy and safety of brain implants. However, ethical and privacy considerations surrounding brain implants, such as informed consent and data protection, need to be addressed as the field continues to evolve.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Brain Implant Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Brain Implant Market Segmental Analysis

The global brain implants market is segmented based on type, application, end user, and region. In terms of type, the market is divided into deep brain stimulation (DBS) and vagus nerve stimulation (VNS). DBS involves the implantation of electrodes to deliver electrical impulses to specific brain areas, while VNS utilizes electrical stimulation of the vagus nerve for neurological treatment. The market is categorized by application into Parkinson's disease, epilepsy, and other conditions. The end users of brain implant devices include hospitals, neurology clinics, and other healthcare settings. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Brain Implant Market

Increasing Prevalence of Neurological Disorders

  • The rising incidence and prevalence of neurological disorders such as Parkinson's disease, epilepsy, and chronic pain are driving the demand for brain implant technologies. These implants offer effective treatment options for managing symptoms and improving patients' quality of life.

Restraints in the Global Brain Implant Market

Ethical and Privacy Concerns

  • The use of brain implants raises ethical concerns related to informed consent, privacy, and potential misuse of brain data. The invasive nature of brain implant procedures also poses risks and requires careful consideration of the potential benefits and long-term implications for patients.

Market Trends of Global Brain Implant Key

  • One key market trend in the global brain implant market is the increasing focus on miniaturization and wireless connectivity of implantable devices. Advancements in technology have led to the development of smaller, more compact brain implants, reducing the invasiveness of surgical procedures and enhancing patient comfort. Miniaturized implants offer the potential for minimally invasive or even non-invasive approaches, such as transcranial magnetic stimulation (TMS) or non-invasive electrical stimulation techniques. These advancements are particularly important for patients who may benefit from long-term implantation, as smaller devices can reduce the risk of complications and allow for easier implantation and removal.

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
    • Regulatory Landscape
    • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Brain Implant Market by Type
    • Market Overview
    • Deep brain stimulation (DBS) and vagus nerve stimulation (VNS).
  • Global Brain Implant Market by Application
    • Market Overview
    • Parkinson's disease
    • epilepsy
    • and other conditions
  • Global Brain Implant Market by End user
    • Market Overview
    • Hospitals
    • neurology clinics
    • and other healthcare settings
  • Global Brain Implant Market Size by Region
    • Market Overview
    • North America
  • USA
  • Canada
    • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
    • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
    • Latin America
  • Brazil
  • Rest of Latin America
    • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
  • By Development
  • By Company
  • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • Medtronic (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Boston Scientific Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • NeuroPace (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Cochlear Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • LivaNova PLC (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Stryker Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Nevro Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • NDI Medical (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Nihon Kohden Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Second Sight Medical Products, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Aleva Neurotherapeutics SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Renishaw plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Cyberonics, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Neuronetics, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Natus Medical Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • BrainLab AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • St. Jude Medical, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • NeuroSigma, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Alpha Omega Engineering (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments